Credit Suisse Ag Abcam PLC Transaction History

Credit Suisse Ag

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$21.54 - $24.41 $3.13 Million - $3.55 Million	-145,529 Reduced 61.84%	89,787 $2.03 Million
Q2 2023 Aug 11, 2023	SELL	$12.62 - $24.47 $4.15 Million - $8.04 Million	-328,554 Reduced 58.27%	235,316 $5.76 Million
Q1 2023 May 10, 2023	BUY	$12.98 - $17.1 $549,015 - $723,278	42,297 Added 8.11%	563,870 $7.59 Million
Q4 2022 Feb 13, 2023	BUY	$13.92 - $17.0 $7.26 Million - $8.87 Million	521,573 New	521,573 $8.12 Million

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.